samedan logo

home > ict

International Clinical Trials

 International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.

Published quarterly, the journal offers a platform of communication and information-sharing for executive and strategic decision makers, seeking out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.

Prompted by the synergies between trial operations and wider contract research and outsourcing issues, ICT joined forces with sister title European Pharmaceutical Contractor (EPC) in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.
For further information please contact:

Simon Caplan

Caitlin O'Sullivan

Connect with us on Twitter: follow @IntClinTrials


Click here to view the digital version of ICT

Featured in this issue
Achieving Flexibility in Clinical Contract Manufacturing

Katie Farley at MasterControl

The pharma industry relies on quick, effective decision-making from its leaders. To improve efficiency, businesses should utilise contemporary digital solutions in manufacturing
Technology in Trials
Immediate Impact

Liz Brennan at Wellington Eye Clinic

As a result of the COVID-19 pandemic, 70% of all clinical trials are behind schedule. There is a fervent demand for CROs and site-level changes to help streamline clinical trials
  Technology in Trials
Evolution and Revolution in Site Management

Emil Hoeck at Signant Health

While virtual and decentralised trials continue to proliferate and evolve, challenges still remain for sitebased trials. A novel approach to clinical site monitoring could redefine the future of medical research


Published quarterly in
February, May,
August, and November


News and Press Releases

Drug delivery innovation across Europe improves for third consecutive year ahead of Pharmapack Europe

Paris, 25th June 2021: Ahead of Pharmapack Europe 2021 (Paris Expo, Porte de Versailles, 13-14 October) – the returning European event dedicated to drug packaging and delivery – there has been a huge swathe of innovation across the industry, with more than 53 FDA approvals in 2020 and 26 approvals in 2021.
More info >>

White Papers

What is process characterization?


Process characterization is an essential step in the commercialization of a new (biological) drug. For drug product commercialization, manufacturers must validate the drug’s manufacturing process. This ensures that the manufacturing process delivers consistently a quality product and that the patient is not at risk.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement